biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > $200k non-brokered raise

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Feb 19, 2022 8:13am

106 Views

Post# 34444577

RE:RE:RE:RE:RE:$200k non-brokered raise

aacchhhhh,,,,Stockhouse is a better platform. All perspectives should be welcomed. Super impoprtant to understand what shareholder persectives are, why they hold them and if its a legit reason. Technical analysis of the science and competition and business sense, good and bad needs to be out there!

Optimism,,,,pessimism,,,,,fear,,,,,,uncertainty ,,,and doubt must be met with a degree of discussion and when it is we are all a step more intune with where we are,,what we have and where we might be going!

jmo

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?